MTOR and urinary bladder cancer: A standardized extract of R. rosea Swedish Herbal Rhodiola-5 (SHR-5) and its active compound salidroside (IC50 ranged from 70 to 264 μg/mL) inhibited mechanistic target of rapamycin (mTOR), thus suppressing proliferation and upregulating the autophagy processes of human bladder cancer cell lines T24, RT4, 5637, UMUC, and J82 [119].